Cannabis Legalization Linked to Major Drop in Daily Opioid Use Among Injecting Drug Users

New research highlights a significant trend. Adult-use marijuana legalization shows a strong association with declining daily opioid use. This trend is particularly notable among people who inject drugs (PWID). A recent study offers compelling evidence. It was published in the journal Drug and Alcohol Dependence. Researchers from Boston University and Emory University led the analysis….

Read More

Medical Cannabis Research Bias Found: ‘Reverse Spin’ Downplays Benefits

New Study Exposes ‘Reverse Spin Bias’ in Medical Cannabis Findings A significant new study reveals a hidden bias in medical cannabis research. This bias actively downplays positive findings. Researchers have identified a phenomenon called ‘reverse spin bias’. It appears in systematic reviews of medical cannabis for pain. This discovery impacts how we understand cannabis research….

Read More

Groundbreaking Cannabis Trial Shows Migraine Relief Superior to Placebo

New Trial Reveals Cannabis Effectiveness for Migraine Relief A significant medical breakthrough is emerging. The first placebo-controlled trial has found cannabis effective for migraines. This news offers new hope to millions. The study was published in Headache: The Journal of Head and Face Pain. Researchers conducted a rigorous investigation. It involved vaporized cannabis. The results…

Read More

Tech Rebound Soothes Market Jitters as Q4 Earnings Season Delivers Growth

Markets are breathing easier. The tech sector shows strong signs of recovery. This rebound eases recent market anxieties. The fourth-quarter earnings season is well underway. Many companies are reporting strong results. This news provides welcome stability. It calms fears that had recently emerged. Earnings Season Gains Momentum The S&P 500 index is on a positive…

Read More